EVAR Boosts Renal Intervention Risk
WASHINGTON, D.C.—Patients with an endovascular aneurysm repair (EVAR) should be considered a high-risk group for renal artery interventions and receive closer post-procedure surveillance.
WASHINGTON, D.C.—Patients with an endovascular aneurysm repair (EVAR) should be considered a high-risk group for renal artery interventions and receive closer post-procedure surveillance.
Percutaneous nephrolithotomy (PCNL) improves the estimated glomerular filtration rate (eGFR) in patients with stage 5 CKD, but unexpected deterioration in renal function could occur in patients with earlier CKD stages, investigators in Turkey report.
Antihypertensive treatment with perindopril prevents recurrent stroke in CKD patients across a wide spectrum of BP levels, according to Australian and Japanese researchers. They saw no evidence for a higher risk of stroke among individuals with low BP.
Advanced kidney dysfunction independently predicts sudden cardiac death among women with coronary heart disease (CHD).
More than half of African Americans with hypertensive CKD will experience renal disease progression long-term despite tight BP control with drugs that block the renin-angiotensin system (RAS).
STOCKHOLM—More than one third of patients with stage III-IV CKD have restless legs syndrome (RLS), an Italian study found.
GRAPEVINE, Tex.—Higher levels of 25-hydroxyvitamin D (25 (OH) D) may lower the risk of anemia and elevated C-reactive protein levels may raise the risk, according to new study findings that may explain much of the high prevalence of anemia among individuals with kidney disease, researchers conclude.
AMAG Pharmaceuticals, Inc., of Cambridge, Mass., has announced that the FDA has accepted for standard review its New Drug Application (NDA) for ferumoxytol as an IV treatment of iron deficiency anemia in CKD patients.
Universal access to health care might help to overcome racial and ethnic barriers to treatment for kidney disease, according to two studies.
The prevalence of CKD among adults in Beijing, China is 13%, according to a recent study published in the American Journal of Kidney Diseases (2008;51:373-384).